Insider trades
RA Capital Nexus Fund III, Director of Climb Bio CLYM, has filed 33 purchases and 44 sales on the open market. Over the past 12 months that comes to a net purchase of $563.2M. The latest trade was on 09/28.
RA Capital Nexus Fund III
Director
- Company
- Climb Bio CLYM
- First filing
- 23/02/16
- Trades
- 165 trades
- Buys / sales
- 33 / 44
- 12-month net buying
- $563.2M
- Last trade
- 09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ARTV | Open-market buy | 06/25–06/26 | 06/29 | 32,876 sh2 trades | $8.89avg. | $292,126.48 | +0.2% |
ARTV | Open-market buy | 06/12–06/16 | 06/16 | 531,326 sh3 trades | $8.66avg. | $4,599,903.46 | +3.3% |
PBLS | Open-market buy | 06/11 | 06/15 | 21,188,750 sh2 trades | $20.00avg. | $423,775,000 | No record |
ARTV | Open-market buy | 06/09–06/11 | 06/11 | 1,027,722 sh3 trades | $7.44avg. | $7,650,148.29 | +6.8% |
| Open-market buy | 05/11 | 05/13 | 6,510,416 sh | $11.52 | $74,999,992.32 | +74.9% | |
MLYS | Open-market buy | 03/27–03/30 | 03/31 | 369,000 sh2 trades | $23.75avg. | $8,762,797 | +6.8% |
| Open-market buy | 02/26 | 03/02 | 300,000 sh | $16.00 | $4,800,000 | +7.0% | |
SGP | Open-market buy | 02/09 | 02/11 | 3,690,000 sh2 trades | $16.00avg. | $59,040,000 | No record |
Climb BioCLYM | Open-market buy | 01/05 | 01/07 | 7,111 sh | $3.50 | $24,888.5 | +0.2% |
CLYM | Open-market buy | 25/12/11–25/12/12 | 25/12/15 | 314,561 sh2 trades | $2.40avg. | $754,737.14 | +10.2% |
SION | Open-market sale | 25/11/20–25/11/21 | 25/11/24 | 30,316 sh12 trades | $39.61avg. | $1,200,703.87 | −16.0% |
SION | Open-market sale | 25/11/17–25/11/19 | 25/11/19 | 136,351 sh24 trades | $40.34avg. | $5,500,158.01 | −44.8% |
SION | Open-market sale | 25/10/24–25/10/28 | 25/10/28 | 373,610 sh8 trades | $39.51avg. | $14,762,603.8 | −64.1% |
| Open-market buy | 25/09/04 | 25/09/08 | 1,176,470 sh | $25.50 | $29,999,985 | +27.5% | |
| Open-market buy | 25/03/13 | 25/03/17 | 1,296,296 sh | $13.50 | $17,499,996 | +43.4% | |
SION | Open-market buy | 25/02/10 | 25/02/10 | 1,125,000 sh2 trades | $18.00avg. | $20,250,000 | +93.8% |
SEPN | Open-market buy | 24/10/28 | 24/10/30 | 4,170,000 sh2 trades | $18.00avg. | $75,060,000 | No record |
BCAX | Open-market buy | 24/09/16 | 24/09/18 | 1,833,000 sh2 trades | $18.00avg. | $32,994,000 | +223.7% |
ARTV | Open-market buy | 24/07/22 | 24/07/24 | 8,333,333 sh2 trades | $12.00avg. | $99,999,996 | No record |
CLYM | Open-market buy | 24/06/27 | 24/07/01 | 13,008,546 sh2 trades | $3.84avg. | $49,952,816.64 | No record |
